1. Home
  2. GMED vs KNSL Comparison

GMED vs KNSL Comparison

Compare GMED & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • KNSL
  • Stock Information
  • Founded
  • GMED 2003
  • KNSL 2009
  • Country
  • GMED United States
  • KNSL United States
  • Employees
  • GMED N/A
  • KNSL N/A
  • Industry
  • GMED Medical/Dental Instruments
  • KNSL Property-Casualty Insurers
  • Sector
  • GMED Health Care
  • KNSL Finance
  • Exchange
  • GMED Nasdaq
  • KNSL Nasdaq
  • Market Cap
  • GMED N/A
  • KNSL 10.9B
  • IPO Year
  • GMED 2012
  • KNSL 2016
  • Fundamental
  • Price
  • GMED $71.01
  • KNSL $485.76
  • Analyst Decision
  • GMED Buy
  • KNSL Hold
  • Analyst Count
  • GMED 13
  • KNSL 10
  • Target Price
  • GMED $96.91
  • KNSL $476.75
  • AVG Volume (30 Days)
  • GMED 1.3M
  • KNSL 185.2K
  • Earning Date
  • GMED 05-06-2025
  • KNSL 04-24-2025
  • Dividend Yield
  • GMED N/A
  • KNSL 0.14%
  • EPS Growth
  • GMED N/A
  • KNSL 34.49
  • EPS
  • GMED 0.75
  • KNSL 17.78
  • Revenue
  • GMED $2,519,355,000.00
  • KNSL $1,587,525,000.00
  • Revenue This Year
  • GMED $8.52
  • KNSL $16.22
  • Revenue Next Year
  • GMED $6.73
  • KNSL $14.69
  • P/E Ratio
  • GMED $96.47
  • KNSL $27.20
  • Revenue Growth
  • GMED 60.62
  • KNSL 29.65
  • 52 Week Low
  • GMED $49.33
  • KNSL $355.13
  • 52 Week High
  • GMED $94.93
  • KNSL $531.79
  • Technical
  • Relative Strength Index (RSI)
  • GMED 43.99
  • KNSL 57.43
  • Support Level
  • GMED $70.34
  • KNSL $479.38
  • Resistance Level
  • GMED $74.34
  • KNSL $497.81
  • Average True Range (ATR)
  • GMED 3.39
  • KNSL 21.14
  • MACD
  • GMED 0.25
  • KNSL 0.51
  • Stochastic Oscillator
  • GMED 53.31
  • KNSL 73.36

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, a professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

Share on Social Networks: